Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9021 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8986 |
High Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8889 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8803 |
High Similarity |
NPD2800 |
Approved |
0.8794 |
High Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8794 |
High Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8732 |
High Similarity |
NPD1549 |
Phase 2 |
0.8667 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8667 |
High Similarity |
NPD7819 |
Suspended |
0.8643 |
High Similarity |
NPD6651 |
Approved |
0.8633 |
High Similarity |
NPD1240 |
Approved |
0.8618 |
High Similarity |
NPD7075 |
Discontinued |
0.8601 |
High Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8543 |
High Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8533 |
High Similarity |
NPD7411 |
Suspended |
0.8521 |
High Similarity |
NPD1510 |
Phase 2 |
0.8511 |
High Similarity |
NPD1607 |
Approved |
0.8467 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8462 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8462 |
Intermediate Similarity |
NPD6099 |
Approved |
0.8462 |
Intermediate Similarity |
NPD6100 |
Approved |
0.8356 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8355 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8333 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.8312 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8311 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8291 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8288 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8264 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8258 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8255 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8255 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8255 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8231 |
Intermediate Similarity |
NPD3750 |
Approved |
0.82 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8188 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8182 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8141 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8137 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8117 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8105 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8099 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8041 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8038 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8027 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8012 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7972 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7959 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7959 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.795 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.795 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.795 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7939 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7908 |
Intermediate Similarity |
NPD920 |
Approved |
0.7891 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7891 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7881 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7867 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7866 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7857 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7832 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7826 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7818 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7815 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7786 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7785 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7746 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7736 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7724 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7724 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7716 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7716 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7714 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7714 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7712 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7692 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7687 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7687 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7682 |
Intermediate Similarity |
NPD2654 |
Approved |
0.7667 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7655 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7632 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7622 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7619 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7619 |
Intermediate Similarity |
NPD943 |
Approved |
0.7605 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7586 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7564 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7535 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7531 |
Intermediate Similarity |
NPD919 |
Approved |
0.7515 |
Intermediate Similarity |
NPD2403 |
Approved |
0.75 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7484 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7465 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD4362 |
Clinical (unspecified phase) |
0.7443 |
Intermediate Similarity |
NPD4361 |
Phase 2 |
0.7439 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7436 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7417 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7417 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7412 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD3267 |
Approved |
0.7379 |
Intermediate Similarity |
NPD3266 |
Approved |
0.7376 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD411 |
Approved |
0.7358 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7353 |
Intermediate Similarity |
NPD6104 |
Discontinued |
0.7346 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7337 |
Intermediate Similarity |
NPD1729 |
Discontinued |
0.7333 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7333 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7325 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD17 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.7305 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7303 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7294 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7292 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7286 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7279 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7278 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7273 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.726 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7257 |
Intermediate Similarity |
NPD4287 |
Approved |
0.725 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7239 |
Intermediate Similarity |
NPD2296 |
Approved |
0.723 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7219 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7214 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7211 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.7208 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7194 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7192 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7179 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7178 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7178 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7168 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7168 |
Intermediate Similarity |
NPD8312 |
Approved |
0.716 |
Intermediate Similarity |
NPD3446 |
Phase 1 |
0.7152 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7143 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7143 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7135 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7125 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7117 |
Intermediate Similarity |
NPD7577 |
Discontinued |
0.7105 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7105 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7099 |
Intermediate Similarity |
NPD6585 |
Discontinued |
0.7095 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.7075 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7075 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7063 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7045 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7039 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7039 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7039 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7039 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7032 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7025 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7018 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD3787 |
Discontinued |
0.697 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6966 |
Remote Similarity |
NPD4626 |
Approved |
0.6959
|
Remote Similarity |
NPD8651 |
Approved |